Medrxcol
ActiveSummary
The computed 12-month bankruptcy probability of Medrxcol is 3.7% (moderate). The 2025 annual accounts show equity of €169k and a net result of €156k. Equity is growing by ~3.5% per year across the filed fiscal years. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
Axes · tick = 2024
Profitability100▲+3
Solvency83▲+34
Growth78=
Track record94
Bankruptcy probability, 12 months
3.7%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €11k at 30 days acceptable
Liquidity ample (current ratio 2.13 against 1.24 in 2024; short-term debt: 42.1% and cash: 18.3% of total assets), and 42.1% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
57.9%
Return on assets
53.5%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-04-2026, 92 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
92 d early
2024
30 d late
2023
29 d late
2022
30 d late
2021
89 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€169k▲ 0.9%
2024 · €168k
Total assets
€293k▼ 58.4%
2024 · €703k
Net result
€156k▼ 1.2%
2024 · €158k
Working capital
€139k▲ 8.3%
2024 · €128k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€171k-€235k▲ 37.1%€200k▼ 14.7%€205k▲ 2.1%€207k▲ 1.0%
Net result€134k-€165k▲ 23.3%€155k▼ 5.9%€158k▲ 2.2%€156k▼ 1.2%
Equity€134k-€300k▲ 124%€454k▲ 51.7%€168k▼ 63.1%€169k▲ 0.9%
Total assets€189k-€418k▲ 121%€590k▲ 41.2%€703k▲ 19.0%€293k▼ 58.4%
Debt€56k-€119k▲ 113%€136k▲ 14.5%€535k▲ 294%€123k▼ 77.0%
Working capital€134k-€300k▲ 124%€454k▲ 51.7%€128k▼ 71.8%€139k▲ 8.3%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 1% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €293k
Fixed assets
€31k ▼ 22.9%
Current assets
€262k ▼ 60.5%
Equity and liabilities €293k
Equity
€169k ▲ 0.9%
Debt
€123k ▼ 77.0%
Debt's share of the balance-sheet total falls from 76.1% to 42.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€216k▲
2024 · €210k
Cash flow
€166k▲
2024 · €164k
Current ratio
2.13▲
2024 · 1.24
Debt to equity
0.73▼
2024 · 3.19
ROE
92.4%▼
2024 · 94.3%
ROA
53.5%▲
2024 · 22.5%
Interest coverage
723.06▼
2024 · 2763.31
Debt ≤ 1 year
€123k▼
2024 · €535k
Income taxes
€50k▲
2024 · €47k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €2k | - | - | €6k | €9k | ▲ 58.4% |
| Other operating charges640/8 | €168 | €185 | €151 | €1k | €851 | ▼ 34.7% |
| Gross operating margin9900 | €174k | €235k | €201k | €212k | €217k | ▲ 2.3% |
| Operating profit (loss)9901 | €171k | €235k | €200k | €205k | €207k | ▲ 1.0% |
| Financial income75/76B | - | - | - | €417 | - | - |
| Recurring financial income75 | - | - | - | €417 | - | - |
| Financial charges65/66B | - | €201 | €324 | €76 | €299 | ▲ 292% |
| Recurring financial charges65 | - | €201 | €324 | €76 | €299 | ▲ 292% |
| Profit (loss) for the period before taxes9903 | €171k | €235k | €200k | €205k | €206k | ▲ 0.7% |
| Income taxes67/77 | €38k | €70k | €45k | €47k | €50k | ▲ 7.2% |
| Profit (loss) for the period9904 | €134k | €165k | €155k | €158k | €156k | ▼ 1.2% |
| Profit (loss) for the period to be appropriated9905 | €134k | €165k | €155k | €158k | €156k | ▼ 1.2% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €189k | €418k | €590k | €703k | €293k | ▼ 58.4% |
| Fixed assets21/28 | - | - | - | €40k | €31k | ▼ 22.9% |
| Tangible fixed assets22/27 | - | - | - | €40k | €31k | ▼ 22.9% |
| Furniture and vehicles24 | - | - | - | €40k | €31k | ▼ 22.9% |
| Current assets29/58 | €189k | €418k | €590k | €663k | €262k | ▼ 60.5% |
| Amounts receivable within one year40/41 | - | €732 | - | €2k | €4k | ▲ 135% |
| Trade receivables40 | - | €732 | - | - | - | - |
| Other amounts receivable41 | - | - | - | €2k | €4k | ▲ 135% |
| Current investments50/53 | - | €17k | €96k | €132k | €184k | ▲ 39.4% |
| Cash at bank and in hand54/58 | €172k | €369k | €478k | €512k | €54k | ▼ 89.6% |
| Deferred charges and accrued income490/1 | €18k | €31k | €17k | €17k | €21k | ▲ 22.3% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €189k | €418k | €590k | €703k | €293k | ▼ 58.4% |
| Equity10/15 | €134k | €300k | €454k | €168k | €169k | ▲ 0.9% |
| Contributions10/11 | - | €1k | €1k | €1k | €1k | = |
| Reserves13 | - | €298k | €298k | €165k | €165k | = |
| Distributable reserves133 | - | €298k | €298k | €165k | €165k | = |
| Profit (loss) carried forward14 | €134k | €661 | €156k | €2k | €3k | ▲ 73.9% |
| Amounts payable17/49 | €56k | €119k | €136k | €535k | €123k | ▼ 77.0% |
| Amounts payable within one year42/48 | €56k | €119k | €136k | €535k | €123k | ▼ 77.0% |
| Trade debts44 | €3k | - | - | €1k | €193 | ▼ 86.7% |
| Suppliers440/4 | €3k | - | - | €1k | €193 | ▼ 86.7% |
| Taxes, remuneration and social security45 | €40k | €108k | €115k | €47k | €6k | ▼ 88.2% |
| Taxes450/3 | €40k | €108k | €115k | €47k | €6k | ▼ 88.2% |
| Other amounts payable47/48 | €12k | €10k | €20k | €486k | €117k | ▼ 75.9% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €134k | €165k | €155k | €158k | €156k | ▼ 1.2% |
| + Depreciation and write-downs630 | €2k | - | - | €6k | €9k | ▲ 58.4% |
| Operating cash flow (approximation) | €136k | €165k | €155k | €164k | €166k | ▲ 0.9% |
| Investment in fixed assets (approximation) | - | - | - | - | €0 | - |
| Change in cash | - | €197k | €109k | €35k | €-459k | ▼ 1,423% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 30 days late
2024
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 29 days late
2023
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 30 days late
2022
31-12
Financial
Highest result since 2021net €165k ▲23.3%
Operating result €235k, net result €165k, both a record.
31-12
Financial
Equity above €200kEq €300k ▲124%
2 profitable years in a row build equity to €300k.
28-10
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 89 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Schaarbeek · 1 establishment unit since 2021
Ground area
4,076 m²
Building footprint
612 m²
Volume, LiDAR
5,367 m³
2 parcels, Brussels, Wallonia · tallest building 17.3 m, ±5 floors. Linked by address, not a title deed.
7
companies at this address
See who is registered here
1 establishment unit
Medrxcol
since 20212.315.724.451
2 parcels
Wallonia
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21903B0195/00C003 | Brussels | 2,471 m² | 1 · 386 m² | 17.3 m · 5 fl. |
| 93009A0200/00H000 | Wallonia | 1,605 m² | 1 · 226 m² | - |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Identification & contact
Identification
Legal formPrivate limited company
Founded25-03-2021
Fiscal year end31-12
Contact
E-mail
collartj@gmail.com
Scores and ratios are computed by Checked and are not a credit decision.